Section 1: Cardiovascular Disease Prevention, SE: Heinz Drexel, Massimo Piepoli and Josep Perk
1: Hypertension, Robert Zweiker and Sabine Perl
2: Dyslipidaemia, Heinz Drexel
3: Metabolic Syndrome and Diabetes, Christoph Säly
4: Thrombosis, Freek Verheugt
Section 2: Ischaemic Heart Disease, SE: Sven Wassmann and Alexander Niessner
1: Acute Coronary Syndromes, Abhiram Prasad and Claire Raphael
2: Chronic stable angina, Gaetano Antonio Lanza and Antonio De Vita
3: Coronary artery spasm and microvascular angina, Peter Ong and Udo Sechtem
4: Takotsubo Syndrome, Alexander Lyon, Mark Sweeney, and Elmir Omerovic
Section 3: Heart Failure, SE: Faiez Zannad and Theresa McDonagh
1: Heart failure, Faiez Zannad, Joao Pedro Ferreira, and Theresa McDonagh
2: Heart transplantation, Finn Gustafsson and Kasper Rossing
Section 4: Arrhythmias, SE: Antoni Martinez-Rubio and Dan Atar
1: Atrial fibrillation, George Dan and Jan Steffel
2: Supraventricular (narrow complex) tachycardias, Julio Martí
3: Ventricular arrhythmias, Martin Borggrefe, Erol Tülümen, and Josep Brugada
4: Bradyarrhythmias, Haran Burri
5: Syncope, Ricardo Ruiz-Granell
Section 5: Structural heart disease, SE: Claudio Ceconi and Francesca Mantovani
1: Valvular Heart Disease, Francesca Mantovani
2: Myocarditis/ Pericardial Syndromes, Giovanni Boffa and Claudio Ceconi
3: Cardiomyopathy, Giovanni Boffa
4: Pulmonary Hypertension, James Tonkin, Kate Ryan and Brendan Madden
Section 6: Management of cardiovascular disease in pregnancy and lactation and in the presence of co-morbidities, SE: Debasish Banerjee and David Goldsmith
1: Kidney disease, Debasish Banerjee, Robin Ramphul, and David Goldsmith
2: Pregnancy and lactation, Anita Banerjee, Debasish Banerjee, and Vivek Jha
3: Liver disease, Nina Hojs, Aftab Ala, and Debasish Banerjee
Section 7: Major drug interactions, SE: Birgitte Klindt Poulsen and Ljubica Vukelic Andersen
1: Major drug interactions, Maja Hellfritzsch Poulsen and Marlene Lunddal Krogh
Section 8: Cardiovascular drugs from A to Z, SE: Juan Tamargo
1: Cardiovascular drugs from A to Z, Juan Tamargo, Ricardo Caballero and Eva Delpón
Section 9: Non-cardiac drugs affecting the heart - from A to Z, SE: Juan Tamargo
1: Non-cardiac drugs affecting the heart, Eva Delpón and Juan Tamargo
The ESC Handbook on Cardiovascular Pharmacotherapy, based on the most recent guidelines in cardiovascular pharmacology, and containing a comprehensive A-Z formulary of common and less commonly used cardiac drugs and drug groups, provides practical and accessible guidance on all areas of drug prescribing.
Previously published as Drugs in Cardiology, this new edition has been developed by the ESC Working Group on Cardiovascular Pharmacology. Pharmacology is an integral aspect in almost all disciplines within cardiology and all cardiologists use cardiovascular drugs.
Completely updated and aligned with the ESC Clinical Practice Guidelines for prescribing, this handbook is essential reading for consultants, registrars in training, general practitioners, specialist cardiac nurses and cardiovascular pharmacologists.
- Developed by experts from the ESC Working Group on Cardiovascular Pharmacotherapy
- Completely updated and aligned with the ESC Clinical Practice Guidelines for cardiovascular pharmacology
- Contains comprehensive A-Z formulary of common and less commonly used cardiac drugs and drug groups
- Essential reading for consultants, registrars in training, general practitioners, specialist cardiac nurses and cardiovascular pharmacologists
- Online access to the digital version on Oxford Medicine Online is included with the purchase of the print book
- Updated online annually
New to this Edition:
- Completely updated and aligned with the ESC Clinical Practice Guidelines for prescribing.
- Updated and comprehensive A-Z formulary.
Edited by Juan Carlos Kaski, Cardiovascular Sciences Research Centre, St George's University of London, UK, and Keld Per Kjeldsen, Department of Medicine (Division of Cardiology), Copenhagen University Hospital (Holbaek Hospital), Holbaek and Department of Health Science and Technology, The Faculty of Medicine, Aalborg University, Aalborg, Denmark.
Professor Kaski is the Immediate Past Director of the Cardiovascular and Cell Sciences Research Institute, St George's, University of London. He is Doctor of Science, University of London, Fellow of the Royal College of physicians (London), the European Society of Cardiology, the American College of Cardiology and the American Heart Association, among over 20 other scientific societies worldwide. He is Deputy Editor in Chief, International Journal of Cardiology, Editor in Chief, European Cardiology Review and the Cardiovascular Pharmacotherapy book series, ISCP.
Professor Kjeldsen is author of over 200 papers and multiple books. Presenter of over 100 lectures nationally and internationally, he is Chairman at 45 scientific sessions. He has extensive experience as peer reviewer at scientific journals, from editorial boards, as chairman and organizer of meetings and congresses and as examiner of theses and research projects nationally and internationally. Teaching interests include Cardiology, cardiovascular pharmacology, and research methodology.